These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27796482)

  • 1. [Therapeutic administration of immunoglobulins].
    Witte T
    Z Rheumatol; 2016 Dec; 75(10):956-963. PubMed ID: 27796482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous immunoglobulin (IVIG)].
    Hara M
    Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
    Ramos-Casals M; García-Hernández FJ; de Ramón E; Callejas JL; Martínez-Berriotxoa A; Pallarés L; Caminal-Montero L; Selva-O'Callaghan A; Oristrell J; Hidalgo C; Pérez-Alvarez R; Micó ML; Medrano F; Gómez de la Torre R; Díaz-Lagares C; Camps M; Ortego N; Sánchez-Román J;
    Clin Exp Rheumatol; 2010; 28(4):468-76. PubMed ID: 20525449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of human immunoglobulins--adverse reactions].
    Pituch-Noworolska A; Błaut-Szlósarczyk A; Zwonarz K
    Pol Merkur Lekarski; 2010 Sep; 29(171):202-5. PubMed ID: 20931833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases.
    Hoffmann JHO; Enk AH
    J Dtsch Dermatol Ges; 2017 Dec; 15(12):1211-1226. PubMed ID: 29228499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children].
    Zeman K; Cywińska-Bernas A
    Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?
    Iaccarino L; Rampudda M; Canova M; Della Libera S; Sarzi-Puttinic P; Doria A
    Autoimmun Rev; 2007 Jan; 6(3):190-5. PubMed ID: 17289556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intravenous immunoglobulin in rheumatic diseases.
    Cruz-Esteban C; Hoffman GS
    Cleve Clin J Med; 1996 Oct; 63(6):340-3. PubMed ID: 8917986
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergency situations in rheumatology with a focus on systemic autoimmune diseases.
    Vymetal J; Skacelova M; Smrzova A; Klicova A; Schubertova M; Horak P; Zadrazil J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):20-9. PubMed ID: 26868300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
    Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for IVIG in rheumatic diseases.
    Mulhearn B; Bruce IN
    Rheumatology (Oxford); 2015 Mar; 54(3):383-91. PubMed ID: 25406359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
    Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
    Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of plasmapheresis and immunoadsorption in salvage therapy of rheumatological diseases].
    Boser M; Kielstein JT
    Z Rheumatol; 2016 Dec; 75(10):964-972. PubMed ID: 27807630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.